mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.002 |